AAOS Now, February 2016
-
Studies on ACL-Deficient Knees, and More Receive Awards
The Society of Military Orthopaedic Surgeons (SOMOS) honored research on the use of local antibiotics in contaminated open fractures, as well as on anterior cruciate ligament (ACL) deficiency in knees and chronic exertional compartment syndrome of the lower leg at its 2015 annual meeting, held Dec.7–11, 2014, in St. Petersburg, Fla. The CDR Michael T. Mazurek Clinician Scholar Award and the COL Brian Allgood Memorial Leadership Award were also presented.
-
THA, Tranexamic Acid, Bupivacaine Papers Receive Awards
A study on conversion total hip arthroplasty (THA), the procedure in which a previous hemiarthroplasty or other reconstruction is converted to a total joint replacement, was recognized for outstanding research during the 2015 annual meeting of the American Association of Hip and Knee Surgeons.
-
Study Finds MCP Arthroplasty Safe, Successful
A promising treatment for patients with inflammatory arthritis, according to a paper presented at the 2016 annual meeting of the American Association of Hand Surgeons, is metacarpophalangeal (MCP) arthroplasty. This study compared the most common implant designs in terms of implant survival rates, finger and hand function, and surgical complications. The researchers, all of whom are from the Mayo Clinic in Rochester, Minn.
-
The Case for a Dedicated Orthopaedic Skills Month during PGY-1
In 2013, sweeping changes were implemented for the PGY-1 (intern) year for categorical orthopaedic surgery residents. These changes reflected mandates from the Accreditation Council for Graduate Medical Education (ACGME) and American Board of Orthopaedic Surgery (ABOS). The most noticeable changes included: (1) a change from 3 to 6 months of mandatory orthopaedic surgery rotations and (2) a mandatory surgical skills curriculum during the intern year.
-
Second Look – Clinical News and Views
These items originally appeared in AAOS Headline News Now, a thrice-weekly enewsletter that keeps AAOS members up to date on clinical, socioeconomic, and political issues, with links to more detailed information. Subscribe at www.aaos.org/news/news.asp (member login required) —A lab animal study published in Molecular Therapy (online) suggests that parathyroid hormone (PTH) injections may complement intravenous mesenchymal stem cell (MSC) therapy in inducing fracture repair.